Section Arrow
ICUI.NASDAQ
- ICU Medical
Quotes are at least 15-min delayed:2026/02/19 06:28 EST
Pre Market
Last
 154.01
+2.38 (+1.57%)
Bid
60.66
Ask
240.88
High 154.01 
Low 146.5 
Volume 61 
Regular Hours (Closed)
Last
 151.63
+3.34 (+2.25%)
Day High 
154.24 
Prev. Close
148.29 
1-M High
160.29 
Volume 
345.27K 
Bid
60.66
Ask
240.88
Day Low
147.82 
Open
148.29 
1-M Low
140.66 
Market Cap 
3.66B 
Currency 美元 
P/E -- 
%Yield -- 
10-SMA 149.25 
20-SMA 150.74 
50-SMA 148.7 
52-W High 162.11 
52-W Low 107 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-0.32/9.34
Enterprise Value
5.24B
Balance Sheet
Book Value Per Share
86.17
Cash Flow
Cash Flow Yield
0.04
Income Statement
Total Revenue
1.32B
Operating Revenue Per Share
91.11
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
BAXBaxter International21.87+1.13+5.45%-- 
Pre Market 21.97 +0.1 +0.46%
AVTRAvantor9.27+0.22+2.43%-- 
Pre Market -- -- --
XRAYDENTSPLY SIRONA12.49+0.05+0.40%-- 
Pre Market 13.19 +0.7 +5.60%
NVSTEnvista Holdings Corp28.5+0.43+1.53%100.25PE
Pre Market 27.01 -1.49 -5.23%
HOLXHologic75.2+0.05+0.07%31.18PE
Pre Market -- -- --
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems(30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.